CDK9 Inhibitors Push Cancer Cells over the Edge

被引：5
|
作者：
Nowicki, Matthew W. [1 ]
Walkinshaw, Malcolm D. [1 ]
机构：
[1] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland
来源：
CHEMISTRY & BIOLOGY | 2010年 / 17卷 / 10期
关键词：
P-TEFB; FLAVOPIRIDOL;
D O I：
10.1016/j.chembiol.2010.10.003
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1047 / 1048
页数：2
相关论文
共 50 条
  • [41] Targeting CDK9: A novel biomarker in the treatment of endometrial cancer
    He, Shasha
    Fang, Xiaoling
    Xia, Xiaomeng
    Hou, Tao
    Zhang, Tingting
    ONCOLOGY REPORTS, 2020, 44 (05) : 1929 - 1938
  • [42] BET and CDK9 protein inhibitors: Novel epigenetic therapy to synergistically kill human melanoma cells
    Al Emran, Abdullah
    Tseng, Hsin-Yi
    Gunatilake, Dilini
    Cook, Stuart
    Tiffen, Jessamy
    Gallagher, Stuart
    Hersey, Peter
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Targeting CDK9: a promising therapeutic opportunity in prostate cancer
    Rahaman, Muhammed H.
    Kumarasiri, Malika
    Mekonnen, Laychiluh B.
    Yu, Mingfeng
    Diab, Sarah
    Albrecht, Hugo
    Milne, Robert W.
    Wang, Shudong
    ENDOCRINE-RELATED CANCER, 2016, 23 (12) : T211 - T226
  • [44] Selective Control of Gene Expression by CDK9 in Human Cells
    Garriga, Judit
    Xie, Hongbo
    Obradovic, Zoran
    Grana, Xavier
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 222 (01) : 200 - 208
  • [45] Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy
    Alsfouk, Aisha A.
    Alshibl, Hanan M.
    Altwaijry, Najla A.
    Alsfouk, Bshra A.
    Al-Abdullah, Ebtehal S.
    MONATSHEFTE FUR CHEMIE, 2021, 152 (01): : 109 - 120
  • [46] Synthesis and biological evaluation of seliciclib derivatives as potent and selective CDK9 inhibitors for prostate cancer therapy
    Aisha A. Alsfouk
    Hanan M. Alshibl
    Najla A. Altwaijry
    Bshra A. Alsfouk
    Ebtehal S. Al-Abdullah
    Monatshefte für Chemie - Chemical Monthly, 2021, 152 : 109 - 120
  • [47] Addressing Transcriptional Dysregulation in Cancer through CDK9 Inhibition
    Toure, Mohammed A.
    Koehler, Angela N.
    BIOCHEMISTRY, 2023, 62 (06) : 1114 - 1123
  • [48] Selective inhibition of CDK9 in triple negative breast cancer
    Mustafa, Ebtihal H.
    Laven-Law, Geraldine
    Kikhtyak, Zoya
    Nguyen, Van
    Ali, Simak
    Pace, Alex A.
    Iggo, Richard
    Kebede, Alemwork
    Noll, Ben
    Wang, Shudong
    Winter, Jean M.
    Dwyer, Amy R.
    Tilley, Wayne D.
    Hickey, Theresa E.
    ONCOGENE, 2024, 43 (03) : 202 - 215
  • [49] Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
    Zhang, Hanghang
    Pandey, Somnath
    Travers, Meghan
    Sun, Hongxing
    Morton, George
    Madzo, Jozef
    Chung, Woonbok
    Khowsathit, Jittasak
    Perez-Leal, Oscar
    Barrero, Carlos A.
    Merali, Carmen
    Okamoto, Yasuyuki
    Sato, Takahiro
    Pan, Joshua
    Garriga, Judit
    Bhanu, Natarajan V.
    Simithy, Johayra
    Patel, Bela
    Huang, Jian
    Raynal, Noel J. -M.
    Garcia, Benjamin A.
    Jacobson, Marlene A.
    Kadoch, Cigall
    Merali, Salim
    Zhang, Yi
    Childers, Wayne
    Abou-Gharbia, Magid
    Karanicolas, John
    Baylin, Stephen B.
    Zahnow, Cynthia A.
    Jelinek, Jaroslav
    Grana, Xavier
    Issa, Jean-Pierre J.
    CELL, 2018, 175 (05) : 1244 - +
  • [50] Selective inhibition of CDK9 in triple negative breast cancer
    Ebtihal H. Mustafa
    Geraldine Laven-Law
    Zoya Kikhtyak
    Van Nguyen
    Simak Ali
    Alex A. Pace
    Richard Iggo
    Alemwork Kebede
    Ben Noll
    Shudong Wang
    Jean M. Winter
    Amy R. Dwyer
    Wayne D. Tilley
    Theresa E. Hickey
    Oncogene, 2024, 43 : 202 - 215
12345